T1	Participants 303 371	21 obese subjects imperfectly controlled by 20 mg of glyburide daily
T2	Participants 600 650	Eleven subjects using insulin plus 10 mg glyburide
T3	Participants 982 1004	combined therapy group
T4	Participants 1204 1222	insulin-only group
